"However, if this association is causal, the population-attributable fractions indicate that around 10% of dementia diagnoses are attributable to anticholinergic drug
exposure, which would equate, for example, to around 20,000 of the 209,600 new cases of dementia per year in the United Kingdom," the researchers stated in the study.
"In determining whether anticholinergic drug
exposure has a causal role in clinical dementia in Parkinson disease, future studies may take a clinical trial approach, in which high-potency anticholinergic medications are replaced with lower-potency alternatives, and the change in cognitive testing and cognitive trajectory are measured," Dr.
SAN DIEGO -- A topical anticholinergic drug
, glycopyrronium tosylate, was as safe and effective for treating hyperhidrosis in children 9-16 years old as it was in adults in two phase 3 trials that included 25 treated children, raising the prospect it could become the first drug to gain Food and Drug Administration approval for treating pediatric hyperhidrosis.
Overall, 14,453 cases (35%) and 86,403 controls (30%) were prescribed at least one anticholinergic drug
with an ACB score of 3 (definite anticholinergic activity) during the exposure period.
The researchers found that 35 percent of cases and 30 percent of controls were prescribed at least one anticholinergic drug
during the study period.
The instruments used for this include the Anticholinergic Drug
Scale  and Anticholinergic Risk Scale .
Penehyclidine hydrochloride (PHC) is a new anticholinergic drug
derived from hyoscyamine, which is an anticholinergic agent with a high degree of selectivity for [M.sub.1] and [M.sub.3] receptor subtypes (12).
Patients were eligible for the study if they demonstrated 8 or more voids per day on a 3-day bladder diary (whether or not they had a history of previous anticholinergic drug
Which anticholinergic drug
for overactive bladder symptoms in adults.
Procyclidine is an anticholinergic drug
principally used for the treatment of Drug-induced Parkinsonism, Parkinson disease and others.
A longitudinal cohort study found that patients taking anticholinergic drugs
had an 80% prevalence of MCI, compared with a 35% prevalence in a matched population of patients not using these drugs; yet Alzheimer's disease hadn't increased among the anticholinergic drug
users at 8-year follow-up.